The Laboratory, Endocrine and Neurotransmitter Symposium (LENS) combines curriculum driven by research and real-world clinical scenarios, taught by engaging and seasoned practitioners and educators. Attendees return year after year to LENS, leaving the weekend with a full toolkit of clinical tips, protocols, and practical applications that can be implemented right away in their practice.

 

Registration Options:

Attend IN-PERSON in Costa Mesa! Purchase 2 or more tickets for extra savings.  

Ticket pricing

Early bird rates available through February 1, 2027:

1 ticket: $499 (regular price $549)
2 or more tickets: $399 each (regular price $449 each)

Live stream not available. All sessions will be held live in Orange County (Costa Mesa.)  

 
 

 

Registration Includes:

  • 14.5 AMA PRA Category 1 Credit(s)

  • Recordings of all presentations

  • Lunch, snacks, and evening reception with raffle prizes

  • Live Q&A panels with speakers

  • Intimate networking opportunities all weekend to interact with colleagues, speakers, and select exhibitors

 
 

 

Schedule


All sessions are presented in Pacific Time

Select any session to view more information

Friday February 26, 2027

  1. 8:15 - 8:30
    Welcome and Announcements
  2. 8:30 - 9:30
  3. 9:30 - 10:30
  4. 10:30 - 11:00
    Networking and Exhibitor Break
  5. 11:00 - 12:00
  6. 12:00 - 1:00
    Lunch Break
  7. 1:00 - 2:00
  8. 2:00 - 3:00
  9. 3:00 - 3:30
    Networking and Exhibitor Break
  10. 3:30 - 4:30
  11. 4:30 - 5:30
  12. 5:30 - 6:30
    Networking reception with light refreshments

Saturday February 27, 2027

  1. 8:00 - 9:00
  2. 9:00 - 10:00
  3. 10:00 - 10:30
    Networking and Exhibitor Break
  4. 10:30 - 11:30
  5. 11:30 - 12:30
  6. 12:30 - 1:30
    Lunch Break
  7. 1:30 - 2:30
  8. 2:30 - 3:30
  9. 3:30 - 4:00
    Networking and Exhibitor Break
  10. 4:00 - 4:30
  11. 4:30 - 5:30

About This Session

 

 

Overview and Learning Objectives

Although simple intervention and basic hormone balancing may prove effective in a majority of cases, many patients will present with symptoms and underlying conditions that involve multi- layers of physiologic dysregulation and these cases can be more complex and challenging.  Even after years of experience with bioidentical hormone treatments and working to balance neuroendocrine symptoms, difficult and complex cases continue to arise. It is evident that there is a need for a more complete and deeper evaluation of the neuroendocrine system, encompassing information regarding inflammation, diet, metabolism, and gastrointestinal health, with the relationship between hormone imbalances and neurotransmitter fluctuations. 

At the conclusion of the weekend, participants will be able to identify the nuances of hormone balancing, the complex relationship between sex hormones, the HPA axis, neurotransmitters, and microbiome health, and recognize the complicated symptom presentation that can result from these imbalances.  Discussion will be heavily based on current research and actual clinical cases, including pitfalls of practice and clinical pearls from seasoned practitioners. Participants will gain additional clinical insight and treatment considerations to evaluate some of the most prevalent and challenging conditions that patients present with, including menopause, andropause, depression, anxiety, altered mental focus and stamina, gastrointestinal issues, sexual dysfunction, sleep disturbances, impaired methylation, mitochondrial health, neuroinflammation, and chronic disease in general. 

Upon completion of this activity, participants will be able to… 

  1. Recognize the nuances of hormone balancing and the complex relationships among sex hormones, the HPA axis, neurotransmitters, and the microbiome, and correlate these interactions with common clinical symptom patterns. 

  2. Examine the role of hormonal, neurological, gastrointestinal, and metabolic factors in conditions such as menopause, depression, anxiety, cognitive dysfunction, sleep disturbances, cardiovascular disease, autoimmunity, and chronic disease. 

  3. Apply foundational microbiome concepts, stool-testing methodologies, and key gastrointestinal biomarkers to identify patterns of dysbiosis and develop evidence-informed clinical strategies for optimizing gut health. 

  4. Characterize the bidirectional relationship between menopausal hormone changes and gastrointestinal function, and determine when GI dysfunction may contribute to hormone-related symptoms and influence clinical management. 

  5. Describe the roles of key neurotransmitters and their interactions with the HPA axis and sex hormone signaling in regulating symptoms such as mood, energy, sleep, and cognitive function. 

  6. Integrate an evidence-informed framework for recognizing neurotransmitter dysregulation and developing targeted therapeutic strategies within the context of endocrine and stress physiology. 

  7. Interpret urinary hormone metabolite patterns, including estrogen and androgen metabolism, enzyme activity, and waking cortisol measurements, to assess hormone physiology and related clinical concerns. 

  8. Explain the regulation of NAD⁺/NADH balance, evaluate the mechanisms and clinical factors that influence NAD⁺ status and testing, and apply an evidence-based framework to interpret results and determine the appropriateness of NAD⁺ precursor supplementation. 

  9. Analyze the interplay between the gut microbiome and mitochondrial function, evaluate how microbial metabolites, dysbiosis, and barrier dysfunction influence mitochondrial health and inflammaging, and apply microbiome testing results to develop targeted interventions that support mitochondrial resilience and function. 

  10. Differentiate the clinical features of testosterone deficiency, understand how hypogonadism is properly diagnosed, and interpret basic and advanced hormone markers including total testosterone, free testosterone, SHBG, LH, FSH, and prolactin. 

  11. Describe and apply a patient-centered approach to testosterone replacement and optimization, including differentiation of TRT and optimization strategies, selection of delivery methods, interpretation of advanced laboratory monitoring, consideration of fertility and reproductive health, recognition of safety and monitoring requirements, and evaluation of emerging therapies such as peptides. 

  12. Integrate the role of methylation in epigenetic regulation, neurotransmitter metabolism, detoxification, cellular repair, and membrane function by evaluating the folate, methionine, remethylation, and transsulfuration pathways, recognizing clinical manifestations of impaired methylation, and interpreting functional and genetic markers to inform personalized clinical decision-making. 

  13. Analyze the role of neuroinflammation in psychiatric and neurological disorders, including microglial activation states, blood-brain barrier dysfunction, and key triggers such as systemic inflammation, gut-brain axis disruption, metabolic dysregulation, and chronic antigenic stress. 

  14. Explain the role of the brain-gut axis in regulating gastrointestinal function, including the interactions among key neural pathways and the mechanisms by which impaired central autonomic output contributes to dysmotility, SIBO, altered gastric acid secretion, and increased intestinal permeability. 

 

CME Credits

This activity has been approved for AMA PRA Category 1 Credit(s)™ and AAPA Category 1 CME credits.

See final CE activity announcement for specific details.

 

 

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Doctor’s Data. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


 

Physician Assistants
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 14.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.